Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.
about
Theiler's virus infection: a model for multiple sclerosisAxonal degeneration as a self-destructive defense mechanism against neurotropic virus infectionThree immune-mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis.Role for complement in the development of seizures following acute viral infection.Central nervous system pathology caused by autoreactive CD8+ T-cell clones following virus infectionRORγt, but not T-bet, overexpression exacerbates an autoimmune model for multiple sclerosis.Innate but not adaptive immune responses contribute to behavioral seizures following viral infection.Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis.Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity.DA virus mutant H101 has altered CNS pathogenesis and causes immunosuppression.Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection.Lack of correlation of central nervous system inflammation and neuropathology with the development of seizures following acute virus infection.Targeting insulin-like growth factor 1 leads to amelioration of inflammatory demyelinating disease.Evaluating an etiologically relevant platform for therapy development for temporal lobe epilepsy: effects of carbamazepine and valproic acid on acute seizures and chronic behavioral comorbidities in the Theiler's murine encephalomyelitis virus mouseContrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial?Distinct roles for IP-10/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10.Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virusInjection of the sciatic nerve with TMEV: a new model for peripheral nerve demyelination.Infectious RNA isolated from the spinal cords of mice chronically infected with Theiler's murine encephalomyelitis virus.Immunization with structural and non-structural proteins of Theiler's murine encephalomyelitis virus alters demyelinating diseaseSequential polymicrobial infections lead to CNS inflammatory disease: possible involvement of bystander activation in heterologous immunity.Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration.TGF-beta1 suppresses T cell infiltration and VP2 puff B mutation enhances apoptosis in acute polioencephalitis induced by Theiler's virus.Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis.Infiltrating macrophages are key to the development of seizures following virus infection.NBQX, a highly selective competitive antagonist of AMPA and KA ionotropic glutamate receptors, increases seizures and mortality following picornavirus infectionRegulatory role of CD1d in neurotropic virus infection.Contrasting roles for Valpha14+ natural killer T cells in a viral model for multiple sclerosis.Resveratrol exacerbates both autoimmune and viral models of multiple sclerosisTheiler's murine encephalomyelitis virus attachment to the gastrointestinal tract is associated with sialic acid bindingDepletion of Olig2 in oligodendrocyte progenitor cells infected by Theiler's murine encephalomyelitis virus.
P2860
Q24629115-4854CD00-C284-48E8-BCC6-FBAAD874C988Q27487496-02433E4D-1CFD-45B9-B3E1-3E908E31007DQ33778939-D6C93329-7A7B-4BFF-AABF-471518C2A520Q33990591-D56A5CB0-1ABD-4882-9019-47F19C52E6A6Q34142884-9CD9A7E0-B4B5-4319-A347-F6C82167DD82Q34613664-B2FA666A-77AD-44AE-B0DF-47C3FBAD4EF2Q34613704-B223CC6B-7B9F-48AF-BF8A-A59C006F9CC5Q34646572-1A6EA42C-CC56-4B28-9709-0CE933FCFEC3Q35000918-0293A4B9-7DC6-43F9-953F-79E240138862Q35039647-25E9C5D7-F3F5-4045-B4F0-B0759BAD3DE7Q35077723-3515C6D4-D105-42FF-86EF-4D1239FCE47CQ35140456-CD889EEC-EDD0-4C8D-AC05-4812F7FE7BF1Q35144099-44D1B65B-2688-4441-9307-3C90D9D90B7BQ35531800-1A8393E8-0494-43FB-9523-6C36B2DDC826Q35570328-41A13A2B-C228-492E-92EE-C94B23EA4301Q35648177-9841D7E8-A915-4ED8-BEF3-AED9C5B7B09EQ35676304-C703DD2F-D813-4229-8E53-C78F86F9ABE4Q35741728-BB1256D2-E712-45E3-AF2A-A25D6C202DFCQ35784809-966F8202-A476-418A-84BE-771B44C5CB2DQ35911328-8E884527-B4BD-4C60-8F3E-123203ABC448Q36004599-0E858064-2ACF-4066-B867-30E4F10EC8BFQ36095622-D5DA9157-EDB1-449C-ADB7-E4E07C2C6FCEQ36248791-0F9D1D11-D3E0-48BD-BCE1-71F9F21A0571Q36428815-19BBD80A-8E9A-480B-8280-15B02E114F8AQ36559966-80B1A4C5-6B88-467C-85F7-C1256B5A614EQ36880171-D192B4FA-F834-4ED6-A520-356FD5DD6D03Q36933909-6EE9C9DB-8421-4260-92F0-63638CB2B958Q37165250-9D43E3DE-8013-4F84-A59B-2EC57A2425EBQ37271884-880CD671-618B-41FD-BD02-9D049BD3971DQ39900629-9F077A96-C839-49ED-8D52-7A81ABA408E1Q40248517-537DA31F-FB43-4903-9AF0-D11FC42DABDA
P2860
Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Prolonged gray matter disease ...... with a mutation in VP2 puff B.
@ast
Prolonged gray matter disease ...... with a mutation in VP2 puff B.
@en
type
label
Prolonged gray matter disease ...... with a mutation in VP2 puff B.
@ast
Prolonged gray matter disease ...... with a mutation in VP2 puff B.
@en
prefLabel
Prolonged gray matter disease ...... with a mutation in VP2 puff B.
@ast
Prolonged gray matter disease ...... with a mutation in VP2 puff B.
@en
P2093
P2860
P1433
P1476
Prolonged gray matter disease ...... with a mutation in VP2 puff B
@en
P2093
P2860
P304
P356
10.1128/JVI.75.16.7494-7505.2001
P50
P577
2001-08-01T00:00:00Z